Heart Test Laboratories, Inc.

NasdaqCM:HSCS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔌 Hardware & Electronics

🩺 Medical Instruments

Location

United States

Market Cap

USD 8.34 M

Share Price

USD 3.71

Avg Daily Volume

120,130

Change (1 day)

-1.46%

Change (1 year)

3.77%

Change (YTD)

-2.75%

Heart Test Laboratories, Inc. EBIT for the Trailing 12 Months (TTM) ending July 31, 2022: USD -5.46 M

Heart Test Laboratories, Inc. EBIT is USD -5.46 M for the Trailing 12 Months (TTM) ending July 31, 2022. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Competitors

Agilent Technologies, Inc.

USD 117.15

-1.96 -1.65%

Fisher & Paykel Healthcare Corporation Limited

USD 21.97

FPH.NZ

-0.39 -1.76%

Cochlear Limited

USD 194.59

COH.AX

-0.44 -0.22%

Bruker Corporation

USD 33.80

BRKR

+0.07 0.21%

MicroPort Scientific Corporation

USD 1.69

0853.HK

+0.01 0.59%

Venture Corporation Limited

USD 10.34

V03.SI

+0.02 0.19%

Roche Holding AG

USD 339.30

RO.SW

-2.14 -0.63%

Abbott Laboratories

USD 132.00

ABT

-0.44 -0.33%

Thermo Fisher Scientific Inc.

USD 483.76

TMO

-11.05 -2.23%

Boston Scientific Corporation

USD 105.21

BSX

-0.84 -0.79%

Stryker Corporation

USD 384.83

SYK

-7.04 -1.80%

Hitachi, Ltd.

USD 27.87

6501.T

+0.19 0.70%

Analog Devices, Inc.

USD 246.95

ADI

+2.08 0.85%

Medtronic plc

USD 91.10

MDT

-2.12 -2.27%

Keyence Corporation

USD 376.98

6861.T

-3.91 -1.03%

View all

Key Data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)